Media Releases

2020

05/11/2020

PromarkerD clinical assay performance results published

23/10/2020

Proteomics International raises $6m in heavily oversubscribed Placement

16/10/2020

First distribution agreement for PromarkerD immunoassay

12/10/2020

PromarkerD international validation study results published

09/10/2020

Partnership with QIMR Berghofer targets oesophageal cancer

27/07/2020

PromarkerD Intellectual Property portfolio expands

15/06/2020

Big pharma clinical study validates PromarkerD kidney test

25/05/2020

Proteomics International receives COVID-19 research grants

16/04/2020

CE Mark for PromarkerD Immunoassay Kit

07/04/2020

Diagnostics R&D expanded: the Promarker™ Pipeline

31/03/2020

Proteomics International expands study with US big pharma

23/03/2020

Proteomics International to patent biomarkers for diagnosis of endometriosis

23/03/2020

WA company takes further step towards blood test for endometriosis

10/02/2020

PromarkerD presented at Australasian Proteomics conference

14/01/2020

CE Mark for PromarkerD Hub predictive software for DKD

1
2
3
4
5
6
7
8
9
10